Donald J. Hayden Jr., Director at Vitae Pharmaceuticals, Inc (VTAE), sold 16,130 shares at $17.00 ($274K) on 2015-09-21, disclosed to the SEC on 2015-09-22.
Scheduled sale ($274k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RGNX | SELL | 2020-02-07 | $100K | — | Filing → |
| RGNX | SELL | 2020-01-21 | $160K | — | Filing → |
| RGNX | SELL | 2020-01-16 | $1.4M | — | Filing → |